In the United States, May is Hepatitis Awareness Month, and May 19 is National Hepatitis Testing Day. Although care and treatment can be life-saving, many of the estimated 800,000 to 1.4 million persons living with hepatitis B virus (HBV) infection and the estimated 3 million persons living with hepatitis C virus (HCV) infection are unaware of their infection and are not receiving necessary care and treatment ([@b1-393]). Guided by the goals of the 2014 U.S. Department of Health and Human Services *Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis* ([@b1-393]), CDC is working to expand access to HBV and HCV testing, care, and treatment. This issue of *MMWR* reports on the progress of these CDC activities in reaching the national prevention goals.

The first report examines projects (based on the Project ECHO model of videoconference and case-based learning) to strengthen HCV primary care capacity in Arizona and Utah. In the second report, programs in three sites (New York City, Minneapolis-St. Paul, and San Diego) targeted HBV testing for persons born in countries where HBV infection is endemic (≥2% prevalence). Both programs were successful in reaching persons in underserved populations (in predominantly rural settings for hepatitis C and among foreign-born persons for hepatitis B) and linking them to appropriate care and treatment. Broader expansion of programs like these will help prevent HBV and HCV transmission and disease.
